Derek Parry Gastroenter Jewell
#107,716
Most Influential Person Now
Derek Parry Gastroenter Jewell's AcademicInfluence.com Rankings
Derek Parry Gastroenter Jewellmedical Degrees
Medical
#1383
World Rank
#1716
Historical Rank
Gastroenterology
#16
World Rank
#16
Historical Rank

Derek Parry Gastroenter Jewellbiology Degrees
Biology
#5767
World Rank
#8325
Historical Rank
Genetics
#529
World Rank
#605
Historical Rank

Download Badge
Medical Biology
Why Is Derek Parry Gastroenter Jewell Influential?
(Suggest an Edit or Addition)Derek Parry Gastroenter Jewell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls (2007) (9208)
- Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. (2005) (2917)
- Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease (2008) (2621)
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants (2007) (1421)
- Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility (2007) (1227)
- A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 (2000) (1189)
- NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation (2010) (1018)
- Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 (1996) (740)
- A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21 (2007) (686)
- The molecular classification of the clinical manifestations of Crohn's disease. (2002) (643)
- The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review (2002) (614)
- Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls (2010) (600)
- In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope (2000) (572)
- A comparison of budesonide with prednisolone for active Crohn's disease. (1994) (557)
- Intensive intravenous regimen for severe attacks of ulcerative colitis. (1974) (540)
- Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region (2009) (513)
- Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. (1988) (495)
- Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history (1998) (481)
- Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls (2010) (465)
- Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. (2005) (463)
- Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease (2008) (455)
- Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease (2010) (421)
- Predicting outcome in severe ulcerative colitis. (1996) (410)
- Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease (1996) (372)
- Coeliac disease in primary care: case finding study (1999) (355)
- Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease (2005) (338)
- Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. (2005) (338)
- Lymphocyte subset reference ranges in adult Caucasians. (1991) (328)
- Food intolerance and the irritable bowel syndrome. (1989) (311)
- Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial (1974) (303)
- Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. (2002) (282)
- Genetic markers may predict disease behavior in patients with ulcerative colitis. (1997) (279)
- Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility (2000) (268)
- Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. (1986) (266)
- Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. (1983) (256)
- Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. (1984) (250)
- Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. (1999) (249)
- NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population (2003) (245)
- Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. (2000) (244)
- A Comparison of Budesonide and Mesalamine for Active Crohn's Disease (1998) (236)
- Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project (2012) (235)
- Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. (2002) (222)
- The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. (1979) (210)
- Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. (1996) (204)
- The association of autoimmune disorders with inflammatory bowel disease. (1989) (204)
- Ciclosporin use in acute ulcerative colitis: a long-term experience (2005) (199)
- Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. (2009) (199)
- Role of the faecal stream in the maintenance of Crohn's colitis. (1985) (199)
- IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease (2007) (199)
- Contribution of the MHC region to the familial risk of coeliac disease (1999) (189)
- Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. (1995) (187)
- Clinical relevance of advances in genetics and pharmacogenetics of IBD. (2004) (184)
- The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. (2013) (180)
- Fistulating Anal Crohn’s Disease: Results of Combined Surgical and Infliximab Treatment (2006) (172)
- Indeterminate colitis: A review of the concept — What's in a name? (2008) (170)
- Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31 (2003) (168)
- T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. (1981) (168)
- Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling (2009) (167)
- Cancer surveillance in ulcerative colitis (2005) (161)
- Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. (1983) (161)
- Circulating immune complexes in inflammatory bowel disease. (1973) (161)
- Mucosal characteristics of pelvic ileal pouches. (1991) (159)
- Prevalence of CARD15/NOD2 Mutations in Caucasian Healthy People (2007) (156)
- Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. (1989) (152)
- Crohn's disease and pregnancy. (1984) (151)
- Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? (2003) (149)
- Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. (2003) (145)
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. (1992) (143)
- The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link (2000) (142)
- The genetics of inflammatory bowel disease (2001) (139)
- Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's Disease (2009) (137)
- Immune complexes in acute and chronic liver disease. (1978) (136)
- Ulcerative colitis and persistent liver dysfunction. (1983) (135)
- Immune complexes in ulcerative colitis and Crohn's disease. (1977) (133)
- Preventing postoperative recurrence of Crohn's disease (1997) (133)
- Effect of heparin on polymerase chain reaction (1994) (133)
- Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. (1983) (131)
- Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn’s disease (2005) (131)
- Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. (1986) (129)
- Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. (2000) (128)
- Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. (1981) (128)
- Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. (1983) (127)
- Cytokine gene polymorphisms in inflammatory bowel disease. (1996) (126)
- Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. (1986) (126)
- A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. (1998) (124)
- High‐Dose Methylprednisolone in the Treatment of Active Ulcerative Colitis (1988) (120)
- Genetics of inflammatory bowel disease: the role of the HLA complex. (2006) (120)
- T cells in peripheral blood after gluten challenge in coeliac disease (2005) (117)
- Confirmation of the role of ATG16l1 as a Crohn's disease susceptibility gene (2007) (117)
- Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease (2003) (116)
- Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. (1989) (114)
- The efficacy of methotrexate for maintaining remission in inflammatory bowel disease (2002) (114)
- Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). (1997) (113)
- The pathogenesis of celiac disease. (1998) (112)
- Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? (1998) (112)
- Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study (2002) (111)
- Olsalazine in active ulcerative colitis. (1985) (107)
- TUCAN (CARD8) genetic variants and inflammatory bowel disease. (2006) (104)
- Linkage analysis of candidate regions for coeliac disease genes. (1997) (101)
- Long‐term results of recurrence and reoperation after strictureplasty for obstructive Crohn's disease (1995) (101)
- Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients (2004) (100)
- Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype (2007) (100)
- A common CTLA4 haplotype associated with coeliac disease (2005) (98)
- Review article: the genetics of inflammatory bowel disease. (2001) (98)
- The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. (2003) (96)
- The prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease (1994) (94)
- Immune-complex mediated colitis in rabbits. An experimental model. (1978) (92)
- Small bowel gas in severe ulcerative colitis. (1991) (92)
- Inhibition of leucocyte motility by drugs used in ulcerative colitis. (1981) (91)
- Oral cyclosporin for chronic active Crohn's disease: a multicentre controlled trial (1994) (90)
- Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. (1999) (88)
- Outcome of 200 restorative proctocolectomy operations: The John Radcliffe Hospital experience (1997) (87)
- Role of a defunctioning stoma in the management of large bowel Crohn's disease (2002) (86)
- A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. (2001) (86)
- Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon. (1987) (85)
- Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. (1985) (82)
- Clinical and functional outcome after restorative proctocolectomy (1991) (82)
- Recurrence After Abdominal Surgery for Crohn’s Disease (2002) (80)
- Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. (1988) (80)
- The IL-23/IL-17 pathway in inflammatory bowel disease (2012) (79)
- T lymphocyte subsets in inflammatory bowel disease: peripheral blood. (1983) (78)
- Cyclosporin A retention enemas in refractory distal ulcerative colitis and 'pouchitis'. (1993) (78)
- Cap polyposis--an unusual cause of diarrhoea. (1993) (77)
- Susceptibility loci in inflammatory bowel disease (1996) (77)
- Effects of the faecal stream and stasis on the ileal pouch mucosa. (1991) (77)
- Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3) (2001) (77)
- The prevalence, clinical features and association of HLA‐B27 in sacroiliitis associated with established Crohn’s disease (2009) (77)
- Lack of association of MYO9B genetic variants with coeliac disease in a British cohort (2006) (76)
- Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility (2006) (75)
- Long‐term outcome after admission for acute severe ulcerative colitis in Oxford: The 1992–1993 cohort (2009) (75)
- MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease (2009) (73)
- Cyclosporine for induction of remission in Crohn's disease. (2005) (73)
- Ten‐year experience of strictureplasty for obstructive Crohn's disease (1989) (73)
- Crohn's disease: genetic susceptibility, bacteria, and innate immunity (2001) (72)
- In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease. (1991) (71)
- Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis. (2003) (69)
- A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. (1990) (69)
- NOD2 (CARD15), the first susceptibility gene for Crohn's disease (2001) (69)
- Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. (1988) (68)
- Chronic immune colitis in rabbits. (1979) (68)
- The genetics of NOD-like receptors in Crohn's disease. (2010) (68)
- Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease. (1990) (67)
- Optimum dose of olsalazine for maintaining remission in ulcerative colitis. (1994) (66)
- Infliximab use in Crohn's disease: impact on health care resources in the UK (2005) (66)
- The genetics of inflammatory bowel disease. (1997) (66)
- Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells. (1990) (66)
- Topics in Gastroenterology (1981) (65)
- The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. (2003) (65)
- Pneumococcal infection in patients with coeliac disease (2008) (65)
- The role of phagocytes in inflammatory bowel disease. (1985) (64)
- A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. (1996) (63)
- Circulating antibodies to cow's milk proteins in ulcerative colitis (1972) (63)
- Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas. (1984) (62)
- Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (61)
- The Presence of Anti‐Neutrophil Antibodies Reflects Clinical and Genetic Heterogeneity Within Inflammatory Bowel Disease (1998) (61)
- Short-chain fatty acid irrigation in severe pouchitis. (1989) (61)
- Cytokine gene expression in HIV‐infected intestinal mucosa (1994) (60)
- Spirochaetosis of the human rectum associated with an intraepithelial mast cell and IgE plasma cell response. (1987) (60)
- Salicylates for ulcerative colitis--their mode of action. (1994) (60)
- Inflammatory Bowel Disease Is Linked to 19p13 and Associated with ICAM-1 (2004) (60)
- Medical therapy for induction and maintenance of remission in pouchitis: a systematic review. (1999) (60)
- Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility (1998) (59)
- Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. (1988) (59)
- Management of acute severe colitis. (2003) (59)
- The Genetic Basis of Inflammatory Bowel Disease (2009) (59)
- Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease (2005) (59)
- Intestinal permeability in the ileal pouch. (1996) (58)
- Fulminant Crohn’s colitis after allogeneic stem cell transplantation (2003) (58)
- Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. (1988) (57)
- Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease (2002) (57)
- The contribution of HLA genes to IBD susceptibility and phenotype. (2004) (57)
- Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. (1998) (56)
- Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1. (2004) (55)
- Pharmacotherapy for inducing and maintaining remission in pouchitis. (1998) (54)
- C3 metabolism in ulcerative colitis and Crohn's disease. (1977) (54)
- Lymphocyte and macrophage subpopulations in pelvic ileal pouches. (1991) (54)
- Inflammatory bowel disease: progress toward a gene. (2000) (53)
- Single nucleotide polymorphisms in TNFSF 15 confer susceptibility to Crohn ’ s disease (2005) (52)
- Oral fluticasone propionate in active distal ulcerative colitis. (1992) (52)
- High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. (2002) (51)
- Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study (2001) (50)
- Ulcerative enteritis. (1983) (50)
- Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. (1991) (49)
- Changing pattern of gastric cancer in Oxfordshire. (1992) (48)
- Altered expression of mucins throughout the colon in ulcerative colitis. (1997) (48)
- Association of a Functional Variant in the Wnt Co-Receptor LRP6 with Early Onset Ileal Crohn's Disease (2012) (48)
- Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria. (1992) (48)
- 10 Cytokines and inflammatory bowel disease (1996) (47)
- Mechanism of action of 5-aminosalicylic acid and its derivatives. (1990) (47)
- Ulcerative colitis and HLA phenotype. (1985) (47)
- Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome. (2001) (46)
- Use of an intravenous steroid regimen in the treatment of acute Crohn's disease. (1986) (46)
- Factors inducing relapse in inflammatory bowel disease. (1978) (45)
- Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease (2009) (45)
- Clinical and molecular characteristics of isolated colonic Crohn's disease (2008) (44)
- Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression. (1992) (44)
- Pigbel-like syndrome in a vegetarian in Oxford. (1996) (43)
- Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity. (1986) (43)
- CELL-MEDIATED IMMUNITY TO A SYNTHETIC GLIADIN PEPTIDE RESEMBLING A SEQUENCE FROM ADENOVIRUS 12 (1987) (43)
- Reaginic hypersensitivity in ulcerative colitis (1972) (42)
- Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis. (1989) (42)
- Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. (1995) (42)
- 5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. (1996) (42)
- Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. (1976) (41)
- Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting (2012) (40)
- Humoral immune system in inflammatory bowel disease: I. Complement levels. (1977) (40)
- Long-Term Function After Restorative Proctocolectomy (2005) (40)
- Outcome of restorative proctocolectomy with ileal reservoir for ulcerative colitis: comparison of distal colitis with more proximal disease. (1996) (40)
- Sulphasalazine and derivatives, natural killer activity and ulcerative colitis. (1985) (40)
- Genome screening of coeliac disease (2002) (40)
- Drug therapy of ulcerative colitis. (1992) (40)
- Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers. (2011) (39)
- Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis. (1983) (37)
- Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis. (1992) (37)
- Confirmation of the novel association at the BTNL2 locus with ulcerative colitis. (2009) (36)
- The pharmacogenetics of methotrexate in inflammatory bowel disease (2005) (36)
- Isolation of intestinal mononuclear cells: factors released which affect lymphocyte viability and function. (1984) (36)
- Medical Therapy for Induction and Maintenance of Remission in Pouchitis: A Systematic Review (1999) (36)
- Fine mapping of the IBD1 locus did not identify Crohn disease-associated NOD2 variants: implications for complex disease genetics. (2002) (36)
- Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease. (1990) (35)
- Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with inflammatory change and faecal stasis. (1994) (35)
- Monocytes in inflammatory bowel disease: absolute monocyte counts. (1980) (35)
- The Immunology of Ulcerative Colitis and Crohn’s Disease (1979) (35)
- Recurrence and reoperation after strictureplasty for obstructive Crohn's disease: long-term results [corrected]. (1995) (34)
- Pulmonary function in inflammatory bowel disease. (1978) (34)
- The pharmacogenetics of methotrexate in inflammatory bowel disease. (2005) (34)
- Glycosylation and sulphation of colonic mucus glycoproteins in patients with ulcerative colitis and in healthy subjects. (1993) (34)
- Crypt cell proliferation and HLA-DR expression in pelvic ileal pouches. (1990) (33)
- Azathioprine in Ulcerative Colitis: An Interim Report on a Controlled Therapeutic Trial (1972) (33)
- HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. (1995) (33)
- Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis. (1985) (33)
- Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity. (1980) (33)
- Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. (1992) (33)
- Clinical Implications of Inflammatory Bowel Disease Genetics on Phenotype (2005) (32)
- Meta‐analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis (2013) (32)
- Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease. (1980) (30)
- Effects of olsalazine in the jejunum of the rat. (1987) (30)
- Comparison between Prospective and Retrospective Evaluation of Crohn's Disease Activity Index (2003) (30)
- Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. (1982) (29)
- Genetics of inflammatory bowel disease. (1994) (29)
- Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing. (1980) (29)
- Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestine. (1984) (29)
- Emergence of inflammatory bowel disease 'beyond the West': do prosperity and improved hygiene have a role? (2008) (29)
- Association between genetic variants in myosin IXB and Crohn's disease (2009) (29)
- Exclusion of Linkage of Crohn's Disease to Previously Reported Regions on Chromosomes 12, 7, and 3 in the Belgian Population Indicates Genetic Heterogeneity (2000) (28)
- CARD15 polymorphisms in Behçet's disease (2005) (28)
- Two-Stage Genome-Wide Search in Inflammatory Bowel Disease: Strong Evidence for Susceptibility LOCI on Chromosomes 3, 7 and 12 (1997) (28)
- Mononuclear phagocyte system of human Peyer's patches: an immunohistochemical study using monoclonal antibodies. (1989) (28)
- TAP1 and TAP2 polymorphism in coeliac disease (2004) (27)
- Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease. (1992) (26)
- IN SITU COMPARISON OF PHENOTYPICAL AND FUNCTIONAL ACTIVITY OF INFILTRATING CELLS IN ULCERATIVE COLITIS MUCOSA (1996) (25)
- Gastric function and histology in chronic renal failure. (1979) (25)
- Atopy in inflammatory bowel disease. (1979) (25)
- MRI scanning in perianal Crohn's disease: an important diagnostic adjunct. (1999) (25)
- Two‐stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease (2008) (25)
- Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis. (1989) (25)
- The immunology of inflammatory bowel disease. (1990) (24)
- Coexpression of CD4 and CD8 on peripheral blood T cells and lamina propria T cells in inflammatory bowel disease by two colour immunofluorescence and flow cytometric analysis. (1991) (24)
- DISODIUM AZODISALICYLATE IN ULCERATIVE COLITIS (1981) (23)
- Yersinia colitis associated with Crohn's disease. (1985) (23)
- Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease. (2004) (23)
- Ulcerative colitis and sarcoidosis. (1986) (23)
- Primary sclerosing cholangitis--an immunologically mediated disease? (1985) (22)
- The humoral immune system in inflammatory bowel disease (1978) (22)
- Two-color immunofluorescence and flow cytometric analysis of peripheral blood lymphocyte subsets in Caucasian and Japanese healthy subjects. (1991) (22)
- Characterisation and quantification of mucosal cytokine that induces epithelial histocompatibility locus antigen-DR expression in inflammatory bowel disease. (1992) (22)
- Acute inflammation in ideal pouches(pouchitis) (1991) (22)
- Selective IgA deficiency and Crohn's disease: report of two cases. (1977) (22)
- Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. (1989) (22)
- Genotype‐based phenotyping heralds a new taxonomy for inflammatory bowel disease (2003) (21)
- Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma (1986) (21)
- Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell. (1992) (21)
- Olsalazine in patients intolerant of sulphasalazine. (1987) (20)
- The mononuclear cells of human mesenteric blood, intestinal mucosa and mesenteric lymph nodes: compartmentalization of NK cells. (1984) (20)
- Medical management of severe ulcerative colitis (1988) (20)
- IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. (2006) (19)
- HETEROGENEOUS EXPRESSION OF CARCINOEMBRYONIC ANTIGEN IN THE NORMAL COLON AND UPREGULATION IN ACTIVE ULCERATIVE COLITIS (1996) (19)
- Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy. (1987) (19)
- Functional consequences of mutations in the autophagy genes in the pathogenesis of Crohn's disease (2012) (19)
- Connective tissue changes in Ileal crohn's disease: Relationship to disease phenotype and ulcer-associated cell lineage (2001) (19)
- HLA genes are important phenotype determining genes in the peripheral arthropathies of inflammatory bowel disease (IBD) (1998) (18)
- Analysis of the IBD 5 locus and potential gene-gene interactions in Crohn ’ s disease (2003) (18)
- Immunoregulatory mechanisms in nonspecific inflammatory bowel disease. (1983) (17)
- Therapy Insight: pyoderma gangrenosum—old disease, new management (2005) (17)
- W1223 Genetic Factors Conferring an Increased Susceptibility to Develop Crohn's Disease Also Influence Disease Phenotype, but Do Not Predict it. Results From the IBDChip European Project (2010) (17)
- In vitro model for the assessment of luminal factors on rectal mucosa. (1983) (17)
- Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial. (1980) (16)
- Azathioprine in ulcerative colitis. (1972) (16)
- The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node. (1985) (16)
- Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP. (1983) (16)
- Clinical Gastrointestinal Immunology (1979) (15)
- Factors affecting the spontaneous cell-mediated cytotoxicity of intestinal mononuclear cells. (1984) (15)
- Site of action of platelet-activating factor within the mucosa of rabbit distal colon. (1995) (15)
- Inflammatory bowel disease is associated with a functional TNF polymorphism that affects an OCT1/NF-KB transcription factor interaction (2002) (15)
- Two-color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's Disease (1991) (15)
- Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life (2002) (15)
- Immunology of inflammatory bowel disease. (1987) (15)
- Colitis: Diagnosis and Therapeutic Strategies (2006) (15)
- A locus telomeric toHLA-DPB encodes susceptibility to coeliac disease (2006) (15)
- Clq metabolism in ulcerative colitis and Crohn's disease. (1979) (15)
- Sacroiliac joint uptake ratios in inflammatory bowel disease: relationship to back pain and to activity of bowel disease. (1982) (14)
- Ulcerative colitis (1992) (14)
- Production of epithelial cell growth factors by lamina propria mononuclear cells. (1992) (14)
- Lactulose hydrogen breath test in the diagnosis of bacterial overgrowth. (1990) (14)
- Subcellular localisation of vitamin B12 during absorption in the guinea-pig ileum. (1981) (14)
- Inhibition of leucocyte motility and prevention of immune-complex experimental colitis by hydroxychloroquine. (1982) (13)
- Acquired double pylorus. (1978) (13)
- Human colonic intraepithelial lymphocytes suppress in vitro immunoglobulin synthesis by autologous peripheral blood lymphocytes and lamina propria lymphocytes. (1993) (13)
- Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31 (2003) (13)
- Risks and benefits of azathioprine therapy (2005) (13)
- A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease. (1995) (12)
- The diagnosis of the site of upper gastrointestinal haemorrhage in patients with established portal hypertension. (1977) (12)
- Association of caspase-9 and RUNX3 with inflammatory bowel disease. (2011) (12)
- Inflammatory Disease of the Bowel (1980) (12)
- The role of platelet-activating factor in the pathogenesis of gastrointestinal disease. (1994) (11)
- Cytokines and inflammatory bowel disease. (1996) (11)
- Smoking benefits celiac sprue and pouchitis: implications for nicotine therapy? (1997) (11)
- Retinal periphlebitis in ulcerative colitis. (1990) (11)
- Effect of human intestinal macrophages on immunoglobulin production by human intestinal mononuclear cells isolated from patients with inflammatory bowel disease (1990) (11)
- Regional differences in the response to platelet-activating factor in rabbit colon. (1992) (11)
- Alpha-chain disease diagnosed by rectal biopsy. (1980) (11)
- Sulfasalazine-induced impotence: a beneficial resolution with olsalazine? (1989) (11)
- Studies on monocytes in inflammatory bowel disease: factors influencing monocyte lysosomal enzyme activity. (1980) (11)
- Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine — A 30 year study (2000) (10)
- Advances in mucosal immunology. (1997) (10)
- Macrophage and lymphocyte subpopulations in magnifying endoscopic lesions of Crohn's disease. (1988) (10)
- Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity. (2000) (10)
- Cellular hypersensitivity to gluten derived peptides in coeliac disease. (1987) (10)
- Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis. (1987) (10)
- Genetics of Inflammatory Bowel Disease. A Personal View on Progress and Prospects (1998) (10)
- Precision mapping of chromosome 12 linkage in IBD: Evidence for a haplotype association (1998) (9)
- Mapping susceptibility loci in inflammatory bowel disease: why and how? (1997) (9)
- Microscopic colitis: can it be qualitatively and quantitatively characterized? (1992) (9)
- Tumour related inhibition of macrophage chemotaxis in patients with colon cancer. (1987) (9)
- The management of acute severe ulcerative colitis. (1991) (9)
- SPLENIC PHAGOCYTIC FUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (1981) (9)
- Response to treatment of microscopic colitis. (1994) (9)
- Salicylates for inflammatory bowel disease. (1994) (9)
- Primary antibody deficiency and Crohn's disease (1999) (9)
- Endocrine function after cimetidine. (1979) (8)
- Novel presentation of coeliac disease after following the Atkins’ low carbohydrate diet (2005) (8)
- Lymphocyte Subpopulations in Volunteers taking Olsalazine (1988) (8)
- CCR5Δ32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis (2000) (8)
- Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization. (1982) (8)
- Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life. (2002) (8)
- [Local immune reaction in human intestinal spirochetosis]. (1987) (8)
- 4 Immunology of inflammatory bowel disease (1987) (8)
- Isolation of parietal cells from guinea-pig gastric mucosa and the immunological characterization of their antigenic structure. (1975) (8)
- Side effects of azathioprine treatment given for inflammatory bowel disease-a 30 year audit (2000) (7)
- Do HLA antigens predict the occurrence of extraintestinal manifestations of IBD? (2008) (7)
- Serumautoantibodies, ulcerative colitis andprimary sclerosing cholangitis (1986) (7)
- ALTERED EXPRESSION OF TGFα AND TGFβ1 IN THE MUCOSA OF THE FUNCTIONING PELVIC ILEAL POUCH (1996) (7)
- Immune Complexes in Inflammatory Bowel Disease (1976) (7)
- Ileal pouch dialysate is cytotoxic to epithelial cell lines, but not to CaCo-2 monolayers. (1997) (7)
- Amplification of toll-like receptor sensitivity by muramyl dipeptide is impaired in crohn's disease associated NOD2 mutations. (2005) (7)
- Autoimmune and inflammatory diseases of the gastrointestinal tract (1976) (7)
- Transmission disequilibrium testing confirms the association of the TNFα 1031C allele with Crohn's disease (2001) (7)
- Recent advances in mucosal immunity (1983) (7)
- Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. (2002) (7)
- Review article: Pathophysiology of the intestinal mucosa in inflammatory bowel disease and arthritis: similarities and dissimilarities in clinical findings (1997) (7)
- Respiratory burst capacity of human intestinal macrophage subpopulations (1990) (7)
- Circulating immune complexes in ulcerative colitis and Crohn's disease. (1972) (7)
- Ulcerative colitis and Crohn's disease—susceptibility genes and clinical patterns (1998) (6)
- The immunology of inflammatory bowel disease (1990) (6)
- Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease. (1992) (6)
- Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitis. (1984) (6)
- Antigenic reactivity of peptides derived from wheat gluten with sera from patients with coeliac disease. (1985) (6)
- Clinical features of erythema nodosum (EN) and uveitis associated with inflammatory bowel disease (IBD) (2000) (6)
- Gastrointestinal amyloidosis complicating psoriatic arthropathy (1981) (6)
- Are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease? (1996) (6)
- Evidence for separate disease phenotypes in intestinal Crohn's disease. (2002) (6)
- Crohn's Disease (2003) (6)
- Infliximab for ulcerative colitis. (2002) (5)
- Preliminary Characterisation of Leucocyte Migration Inhibition Factor (LIF) Produced by Lymphocytes from Coeliac Patients When Stimulated with Gluten Peptides (1987) (5)
- Extraintestinal manifestations of inflammatory bowel disease (IBD) and polymorphisms in the TNFα gene: Further evidence for phenotype determining genes in the MHC region on chromosome 6 (2001) (5)
- Calcium intakes in patients with coeliac disease and inflammatory bowel disease: are they meeting British Society of Gastroenterology guidelines? (2006) (5)
- Tlymphocyte subsets ininflammatory boweldisease: peripheral blood (1983) (5)
- GENETIC MARKERS IN INFLAMMATORY BOWEL DISEASE (1996) (5)
- Coeliac Disease: Possible Mannose-Specific Lectin Activity of Gluten (1985) (5)
- Fine mapping a susceptibility locus on the X chromosome in the Belgian population in inflammatory bowel disease (IBD) (1999) (4)
- Alpha 2-macroglobulin in patients with inflammatory bowel disease. (1980) (4)
- Cimetidine and cerebral blood flow in elderly patients. (1981) (4)
- Current Topics in Immunology Series (1978) (4)
- Proceedings: Immune complexes in ulcerative colitis--an experimental model. (1976) (4)
- Induction of HLA-DR Molecules on a Colonic Epithelial Cell Line by γ-Interferon (γ-IFN) (1988) (4)
- Diagnosis and medical treatment of ulcerative colitis. (1982) (4)
- Identification of HIV-1 viral RNA in intestinal tissue from patients with early and late HIV infection. (1996) (4)
- Vitamin D receptor gene polmorphism further evidence for an association with Crohn's disease (1998) (4)
- Proceedings: Complement in inflammatory bowel disease. (1975) (4)
- Mechanisms of carrageenan injury of cell monolayers. (1989) (4)
- Carnitine as a possible adjunct in parenteral feeding. (1984) (4)
- Benign intracranial hypertension and ulcerative colitis (1972) (4)
- Clinical Dilemmas in Inflammatory Bowel Disease (2007) (4)
- Conditions of the Eyes and Joints Associated with Inflammatory Bowel Disease (2010) (4)
- Class IIantigen (HLA-DR)expression byintestinal epithelial cells ininflammatory diseases ofcolon (1987) (4)
- Studies on the acetylating capacity of human colonic epithelial cells for 5-aminosalicylic acid. (1988) (4)
- A Randomized, Double‐Blind, Placebo‐Controlled Trial of Olsalazine for Active Crohn's Disease (1995) (3)
- Cytokine Production by Human Colonic Intraepithelial Lymphocytes in Controls and Ulcerative Colitis (1994) (3)
- Phenotypic characterization of isolated intraepithelial lymphocytes in patients with ulcerative colitis and normal controls (1992) (3)
- Cytokine Profiles in HIV Infected Intestinal Mucosa (1993) (3)
- The preparation of human intrinsic factor-cobalamin complex from human gastric juice by immunoadsorption. (1984) (3)
- Clinical immunology of the liver and gastrointestinal tract (1987) (3)
- OUTPATIENT PREPARATION FOR COLONOSCOPY (1981) (3)
- Altered expression of TGF alpha and TGF beta 1 in the mucosa of the functioning pelvic ileal pouch. (1996) (3)
- A revised sequence of the human β7 integrin gene (ITGB7) promoter region obtained by inverse PCR (2000) (3)
- Irritable bowel syndrome: is a barium enema necessary? (1986) (3)
- Challenges in inflammatory bowel disease (2006) (3)
- A Method for Investigating the Effects of Drugs on the Prostaglandin Synthetase of Single Rectal Biopsies (1981) (3)
- The Role of Cytokines in Inflammatory Bowel Disease (1994) (3)
- Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid (1996) (3)
- 60 P The 5q31/IBD5 risk haplotype is associated with overall susceptibility to Crohn's disease and determines perianal phenotype (2002) (3)
- Immunoglobulin production byisolated intestinal mononuclear cells frompatients withulcerative colitis andCrohn's disease (1989) (3)
- The immunology of coeliac disease (2004) (3)
- Intestinal mucosal abnormality associated with human immunodeficiency virus infection (1994) (3)
- No evidence for linkage on chromosomes 16-12-7 and 3 in the belgian population may reflect genetic heterogeneity of inflammatory bowel disease (1998) (3)
- Relapse rates on and after stopping azathioprine treatment for inflammatory bowel disease (2000) (3)
- The effect of interleukin-10 and transforming growth factor beta-1 on HLA-DR expression in colonic epithelial cells. (1998) (2)
- Mechanisms of diarrhea in ulcerative colitis. (1993) (2)
- MONOCYTE ACID HYDROLASES IN INFLAMMATORY BOWEL DISEASE (1978) (2)
- Polymorphism at position-1031 in the TNF gene confers susceptibility to Crohn's disease (2000) (2)
- The Immunology of Celiac Disease (1992) (2)
- Prevalence of sacroiliitis in Crohn's disease, and its correlation with clinical, radiologic and genotypic parameters (2002) (2)
- CLINICAL-ALIMENTARY TRACT IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease (2007) (2)
- E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies. (1983) (2)
- Comparative study of carbenoxolone and cimetidine in the management of duodenal ulcer. (1983) (2)
- Innate immunogenetics and nflammatory bowel disease (IBD) (2003) (2)
- Novel polymorphisms in the beta 7 integrin gene (ITGB7): Family based association studies in IBD (2001) (2)
- Association of small intestinal diverticulosis with chronic pancreatitis leading to severe malabsorption. Report of three cases. (1988) (2)
- Optimizing Outcomes in Hepatitis C: Is Treatment Beyond 48 Weeks Ever Justified? (2006) (2)
- Genetics of inflammatory bowel disease--an update. (2001) (2)
- Production of Monoclonal Antibodies with Site-Specific Reactivity in Human Colonic Mucosa (1994) (2)
- HLA-G 14BP insertion-deletion polymorphism influences response to methotrexate in inflammatory bowel disease. (2007) (2)
- Interleukin-23R arg381 gln is associated with susceptibility to Crohn's disease but not with phenotype in an Italian population - Reply (2007) (2)
- Detection of 5-Aminosalicylic Acid (5-ASA) in Rectal Mucosal Biopsies (1987) (2)
- Polymorphisms in the MEP1A Gene: A Role in IBD? (2006) (2)
- Peripheral blood T cells induced by gluten challenge in coeliac disease target a specific molecular motif and express a gut-homing integrin (2001) (2)
- Family based association studies of STAT6, a positional candidate gene for IBD (2001) (2)
- T1243 NOD2 Activation By Muramyl Dipeptide Induces Autophagy in Dendritic Cells in An ATG16l1 Dependent Pathway (2008) (2)
- Monocyte Activity in Crohn's Disease and Ulcerative Colitis (1978) (1)
- The Fate of 125Iodine-Labelled Intrinsic Factor During 57Co-Cyanocobalamin Absorption (1984) (1)
- Intestinal T-cell function. (1982) (1)
- Celiac disease associated with HLA-DQ8 and DQ2 have different T-cell repertoires in vivo (2003) (1)
- Allelic variants of thiopurine methyl transferase are associated with azathioprine induced leukopaenia (2000) (1)
- Absorption of Vitamin B12 in the Guinea-Pig Ileum (1980) (1)
- Natural killer cells andspontaneous cell-mediated cytotoxicity inthehumanintestine (1984) (1)
- Proceedings: Etiology of ulcerative colitis. (1973) (1)
- Infl iximab versus ciclosporin in severe ulcerative colitis (2012) (1)
- Gluten challenge in coeliac disease reveals a single transglutaminase-modified peptide as the dominant T cell epitope in A-gliadin (2000) (1)
- Immunology of the Colon (1983) (1)
- Colorectal cancer inulcerative colitis: acohort study of primary referrals fromthree centres (1988) (1)
- The HLA-G 14bp ins-del polymorphism influences response to methotrexate in inflammatory bowel disease. (2007) (1)
- Articular and ocular complications of inflammatory bowel disease (2003) (1)
- Serum Concentrations of Complement Inhibitors and Immunoconglutinins in Inflammatory Bowel Disease (1979) (1)
- Monocyte Function in Crohn’s Disease (1981) (1)
- Class II Hla Genes in Inflammatory Bowel Disease: Evidence for a Relationship between Genotype and Disease Phenotype (1995) (1)
- Immunological defence mechanisms of the gastrointestinal tract. (1984) (1)
- Discordant sibling pair linkage analysis provides further support for the chromosome 12 inflammatory bowel disease susceptibility locus (2000) (1)
- Effect of Acute Infusion of Cimetidine on Cerebral Blood Flow (1979) (1)
- Identification of a coeliac disease-specific T cell epitope from A-gliadin. (1999) (1)
- I.O.I.B.D. Questionnaire on the clinical use of Azathioprine, 6-Mercaptopurine, Cyclosporine-A and Methotrexate in the treatment of I.B.D (1996) (1)
- Crohn Disease and Ulcerative Colitis (2001) (1)
- Platelet Activating Factor (PAF) has Different effects on Ion Transport and Permeabilty in Proximal and Distal Colon (1991) (1)
- T lymphocyte responses to a synthetic peptide from the human intestinal adenovirus 12 in coeliac disease. (1990) (1)
- characterisation ofintraepithelial lymphocytes ofthehumangastrointestinal tract (1981) (1)
- Macrophage activity in inflammatory bowel disease. (1990) (1)
- Increased expression of carcinoembryonic antigen (CEA) in the normal proximal colon and upregulation in active ulcerative colitis (1995) (1)
- Erratum: Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling (2009) (1)
- Inflammatory bowel disease is associated with functional TNF polymorphism affecting OCT1/NF-kappa B interaction (2002) (1)
- Treatment of Crohn's disease--the new era. (2002) (1)
- Phenotypic concordance and time clustering of diagnosis in multiply affected ibd families : the IOIBD Multiplex Family Collaborative Project, phases I a II (2005) (1)
- Phenotype determining genes in the hla region may determine the presence of uveitis and erythema nodosum (EN) in inflammatory bowel disease (2000) (1)
- The Role of Genetics in Inflammatory Bowel Disease (2008) (1)
- Effect of filtrate containing Clostridium difficile toxin on rectal mucosa maintained in organ culture. (1985) (1)
- Immunology of the Gastrointestinal Tract and Liver (1989) (1)
- Factors Influencing Monocyte Lysosomal Enzyme Activity in Patients with Inflammatory Bowel Disease (1979) (1)
- Macrophage andlymphocyte subpopulations inmagnifying endoscopic lesions ofCrohn's disease (1988) (1)
- HLA class II genes in ulcerative colitis: Strong evidence for a relationship between genotype and clinical phenotype (1995) (1)
- Calcium intakes and osteoporosis screening in patients with coeliac disease, crohn's disease and ulcerative colitis (2008) (1)
- The intercellular adhesion molecule-1 polymorphisms in IBD (2002) (1)
- Bioactivity of peptides homologous to the coeliac disease-specific dominant A-gliadin T cell epitope (2001) (1)
- Correction for Ahmad et al, The molecular classification of the clinical manifestations of Crohn's disease (2003) (1)
- Investigation of the GNAI2 gene in inflammatory bowel disease (2000) (1)
- Tumourrelated inhibition ofmacrophage chemotaxis inpatients withcolon cancer (1987) (0)
- Modulation of Intestinal Nk Activity (1984) (0)
- PERIPHERAL-BLOOD T-CELL SUBSETS IN SCLEROSING CHOLANGITIS (PSC) AND ULCERATIVE-COLITIS (UC) (1985) (0)
- No association between Nod2 polymorphisms and susceptibility to, or progression of, primary sclerosing cholangitis (2002) (0)
- Comparison of outcome following ileal pouch anal anastomosis for distal and total ulcerative colitis (1995) (0)
- therapeutic epitopes and their uses (2003) (0)
- Colonic bacterial proteases toIgA1andsIgAin patients withulcerative colitis (1987) (0)
- Role of pharmacogenetics in the management of inflammatory bowel diseases (2007) (0)
- S1180 Crohn's Disease Is Associated with a Specific Urinary Metabolic Profile (2008) (0)
- Combining clinical risk factors and genotype to predict postoperative recurrence of Crohn's disease (2003) (0)
- SURGERY OF THE STOMACH AND DUODENUM (1949) (0)
- M1032 Managing the Long Term Care of Inflammatory Bowel Disease Patients: the Cost to European Health Care Providers (2010) (0)
- Clqmetabolism inulcerative colitis and Crohn's disease (1979) (0)
- W1257 The Arg381gln SNP in IL 23 R Does Not Influence Response to Immunomodulators in Ulcerative Colitis or Crohn's Disease (2008) (0)
- Selective IgAdeficiency andCrohn's disease: report oftwocases (2011) (0)
- Cöliakidiagnose using a gliadin epitope (2000) (0)
- Adenovirus 12 and Coeliac Disease (1991) (0)
- Innate Immunogcnetics and Inflammatory Bowel Disease (2003) (0)
- The ninety-fifth annual general meeting of the association of physicians of Great Britain and Ireland 2001 (2001) (0)
- Genetic Risk Factors for Severe Ulcerative Colitis Requiring Surgery — the Role of Innate Immunogenetics (2004) (0)
- ULCERATIVE-COLITIS IS DIFFERENTIATED FROM OTHER COLONIC INFLAMMATION BY CD44-V3 AND CD44-V6 EXPRESSION (1995) (0)
- Advanced Therapy of Inflammatory Bowel Disease (2002) (0)
- An In-Vitro Model for Assessment of Luminal Factors on Rectal Mucosa from Patients with Inflammatory Bowel Disease (1981) (0)
- Ulcerative Colitis in Childhood (1973) (0)
- The Effect of Hydrocortisone, Indomethacin and 5 Aminosalicylic Acid (5 ASA) on γ-Interferon(γ-IFN) Induced HLA-DR Expression on a Colonic Epithelial Cell Line (1988) (0)
- Investigation of NOD2 Signaling in Dendritic Cells (2009) (0)
- A case-control investigation using tag SNPs with Crohn's disease that span across the MHC class III (2007) (0)
- Pool sequencing of naturally bound peptides from the HLA class II DQ2 allele and use of this data for T-cell epitope prediction in coeliac disease (1996) (0)
- Regulation of MicroRNAs by NOD2 (2011) (0)
- Investigation of Interleukin 10 Mrna Production in Patients with Active and Inactive Inflammatory Bowel Disease (IBD) (1994) (0)
- Clinical aspects of immunologically mediated intestinal diseases (1994) (0)
- Possible immuno-modulatory activity of gliadin by interference with antigen processing (1997) (0)
- P169 Leukocytapheresis for Ulcerative Colitis - Correlation of Clinical Response with Immune Regulation (2008) (0)
- Tlymphocyte Responses to a Dodecapeptide from Adenovirus 12 in Coeliac Patients (1990) (0)
- Clinics in immunology and allergy Vol 3 No 3 Natural mechanisms of immunity (1985) (0)
- Roleofthefaecal stream inthemaintenance of Crohn's colitis (1985) (0)
- The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes? (2002) (0)
- The Genetics of IBD: How Many Genes Are We Looking for? (2006) (0)
- Replication of HLA-DR associations with disease extent in ulcerative colitis (2000) (0)
- A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension (2000) (0)
- Ankylosing spondylitis (AS) in inflammatory bowel disease (IBD) is associated with possession of HLA-B27 and DR1 (1997) (0)
- Ulcerative colitis andHLA phenotype (2011) (0)
- Binding characteristics of synthetic ligands from A-gliadin to the coeliac disease susceptibility molecules HLA-DQ2/8, and the linked molecules HLA-DR3/4 (1997) (0)
- Preliminary Report of Separate Sites of Iga1 Cleavage by the Streptococcus Sanguis Protease (1984) (0)
- The Fate of125Iodine-Labelled Intrinsic Factor During57Co-Cyanocobalamin Absorption (1984) (0)
- Audit of methotrexate treatment for inflammatory bowel disease (2000) (0)
- The Study of the Ibd Susceptibility Genes on Chromosome 5 and Chromosome 19 (2001) (0)
- Celiac disease. (2000) (0)
- Connective tissue changes in ileal Crohn's disease; relationship to disease phenotype and ulcer associated cell lineage (2000) (0)
- Genetics and Genomics of Chronic Inflammatory Disorders, I: Inflammatory Bowel Disease (2014) (0)
- Crohn's disease andpregnancy. (2011) (0)
- Polymorphisms in the peroxisome proliferator-activated receptor gamma gene are associated with Ileal Crohn's disease (2007) (0)
- An evaluation of the effects of budesonide and mesalamine on the clinical condition of patients with active Crohn's disease (2000) (0)
- Antigenic Reactivity of Gluten Peptides Prepared by High Pressure Liquid Chromatography (1984) (0)
- Genetics of inflammatory bowel disease: Contribution of the X chromosome (1998) (0)
- Chronic immunecolitis inrabbits (2011) (0)
- Immunology of the Gastrointestinal Tract (1980) (0)
- Cytokine genepolymorphisms ininflammatory boweldisease (1996) (0)
- Linkage disequilibrium mapping of the chromosome 12 (IBD2) inflammatory bowel disease susceptibility locus in an enlarged cohort (2003) (0)
- Lipoxygenase and Cyclooxygenase Inhibitors, Sulphasalazine, and Nk Activity (1984) (0)
- Fine Mapping and Positional Candidate Gene Analysis of Chromosome 3p21 in Inflammatory Bowel Disease: Association with CCR5 Δ32 (2000) (0)
- Preparation of Human Intrinsic Factor — 57Co Cyancobalamin (IF-57CoB12) Complex from Gastric Juice (1983) (0)
- Chapter 11. Ulcerative Colitis (2007) (0)
- MECHANISMS IN NONSPECIFIC INFLAMMATORY BOWEL DISEASE (1983) (0)
- Peripheral arthritis and inflammatory bowel disease. (1998) (0)
- The effect of smoking on IL-10, TNFa and IL-6 production in Crohn's disease (2000) (0)
- Modulation of intestinal natural killer activity (1984) (0)
- Epitope diagnostique et therapeutique, et plante transgenique (2000) (0)
- Evidence for An Ileal Origin of Transcobalamin Ii (Tcii) in the Guinea Pig (1982) (0)
- In vivo cross-reactivity of wheat and rye T-cell epitopes in celiac disease (2003) (0)
- Respiratory Burst in Macrophages from Normal and Inflamed Colon (1987) (0)
- Cyclosporine for maintenance of remission in Crohn's disease (1996) (0)
- Epidermal growth factor receptor is associated with evidence of smooth muscle proliferation in Crohn's disease ulcers (2000) (0)
- Transport in Rabbit Caecum: Effect of Low Sodium Solutions (1991) (0)
- S1753 Adult-Onset Coeliac Disease: A Retrospective Analysis of Phenotypic Characteristics with Histological and HLA Correlation (2009) (0)
- Ulcerative Colitis (1980) (0)
- Differential effects of mucin sulphation and O-acetylation in diversion colitis (2000) (0)
- Cytokine production in inflammatory bowel disease. (1994) (0)
- W1258 The Combined Effect of the Aicartase C347g and the Aldehyde Oxidase A3505g SNPs Predict Efficacy of Methotrexate Therapy in Inflammatory Bowel Disease (2008) (0)
- Diagnosis of indigenous sprue / celiac disease with the help of gliadinepitopen (2000) (0)
- REGIONAL DIFFERENCES IN COLONIC PERMEABILITY (1991) (0)
- Discordant sib-pair linkage analysis provides further support for the chromosome 12 inflammatory bowel disease susceptibility locus (2000) (0)
- Genetics of inflammatory bowel disease: why is it important? (2000) (0)
- 12. Ulcerative Colitis (2010) (0)
- P191 The Genetics of NOD-Like Receptors Proteins in Crohn's Disease (2008) (0)
- PERIPHERAL ARTHROPATHIES IN INFLAMMATORY BOWEL DISEASE. AUTHORS' REPLY (1999) (0)
- [New treatments for ulcerative colitis and Crohn's disease]. (1989) (0)
- Coeliac Disease: Inhibition of Leucocyte Migration by Gluten-Derived Peptides (1986) (0)
- White Cell Motility and its Inhibition by Serum Factors and Drugs (1981) (0)
- Subcellular localisation ofvitamin B12during absorption intheguinea-pig ileum* (1981) (0)
- T Lymphocyte Subsets in Patients with Ulcerative Colitis Or Crohn's Disease (1982) (0)
- Handbook of Immunopharmacology of the Gastrointestinal System (1994) (0)
- Split ileostomy andileocolostomy forCrohn's disease of thecolon andulcerative colitis: a20yearsurvey (1983) (0)
- chronic renal failure . Gastric function and histology in (2005) (0)
- M1676 Molecular Mechanism of NOD2 Mediated Autophagy Induction (2010) (0)
- Eresetting lymphocytes ininflammatory bowel disease. Ananalysis using monoclonal antibodies (1983) (0)
- Promoter region polymorphisms of the fas gene (CD95) do not influence susceptibility or disease behaviour in Crohn's disease, ulcerative colitis or primary sclerosing cholangitis (2000) (0)
- Behcet's or Crohn's disease? Combination HLA-B*51 and NOD2 molecular typing may help decide (2002) (0)
- Aetiopathogenesis of ulcerative colitis. (1987) (0)
- Cytokines and inflammatory bowel disease : proceedings from a workshop held at South Lodge Hotel, London, UK, October 1995 (1996) (0)
- cell isolation techniques . analysis by immunohistological and in inflammatory bowel disease : an Intestinal lymphocyte subpopulations (0)
- Strategies Finding IBD Genes (1999) (0)
- Complement Activity in Crohn’s Disease (1981) (0)
- Macrophages in Normal Terminal Ileum and Colon (1988) (0)
- Clinical Trials ñ Past, Present and Future (2002) (0)
- S1681 Investigation of NOD2 Signaling in Dendritic Cells (2009) (0)
- Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data (2019) (0)
- P424 A cost analysis of alicaforsen compared with infliximab or surgery for chronic, unremitting pouchitis in the UK (2012) (0)
- The effect of 5-aminosalicylic acid, hydrocortisone and indomethacin on gamma interferon induced expression of HLA-DR antigens on colonic epithelium. (1993) (0)
- Motility of Intestinal Macrophages in Patients with Colorectal Carcinoma (CA) (1984) (0)
- Is there a role for MICA and MICB in determining susceptibility and phenotype in inflammatory bowel disease (2001) (0)
- NOD2/CARD15: a genetic link between Behcet's disease (BD) and Crohn's disease (CD)? (2003) (0)
- SITE OF PLATELET-ACTIVATING-FACTOR ACTION ON COLONIC MUCOSA (1991) (0)
- Expression ofHLA-DRantigens onbile duct epithelium inprimary sclerosing cholangitis (1988) (0)
- Clinical trial Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis (2006) (0)
- Local immune responses preceding clinical relapse in ulcerative colitis changes in immuno globulin containing cells t lymphocytes and eosinophils (1982) (0)
- Macrophage subpopulations inlamina propria of normal andinflamed colon andterminal ileum (2011) (0)
- NOD2/CARD15 Mutations in the extraintestinal manifestations (EIMs) of inflammatory bowel disease (2003) (0)
- Adaptive Response of Small Intestinal Mucosa in Pelvic Ileal Pouches (1994) (0)
- P017 The miRNA-29 family regulates NOD2-dependent IL-23 expression in human DCs and limits intestinal pathology in a mouse model of mucosal inflammation (2013) (0)
- Formation of granulomata in crohns disease relates to the motility of intestinal macrophages (1985) (0)
- PTU-029 Managing the long-term care of inflammatory bowel disease patients: the cost to European health care providers (2010) (0)
- A urinary metabolic profile associated with Crohn's disease (2008) (0)
- Leucocyte Migration Inhibition in Coeliac Disease by Gluten Peptides (1984) (0)
- Human Colonic Intra-Epithelial Lymphocytes Suppress in vitro Immunoglobulin Synthesis by Autologous Peripheral Blood Lymphocytes (1991) (0)
- Clinical Trials Past, Present and Future (2007) (0)
- Dysregulation of the Host-Commensal Relationship in IBD: Exploring the Role of Angiogenin and Ribonuclease 4 Polymorphisms as Candidate Genes (2006) (0)
- 70 OP Ulcerative colitis susceptibility and clinical heterogeneity clarifying the role of HLA genes (2002) (0)
- Functional variants in the macrophage stimulating 1 receptor gene are associated with Crohn's disease (2008) (0)
- Implications of genetics for clinical practice (2009) (0)
- The pharmacogenetics of methotrexate therapy in inflammatory bowel disease. (2007) (0)
- Investigation of the Inflammatory Bowel Disease Susceptibility Locus on Chromosome 12 (IBD2) (2001) (0)
- α2-Macroglobulin in Inflammatory Bowel Disease (1978) (0)
- Analysis of the CC chemokine receptor 5 (CCR5)Delta 32 polymorphism in Behcet's disease (vol 31, pg 11, 2004) (2005) (0)
- Reply (1997) (0)
- Inflammatory Bowel Disease (1996) (0)
- colitis . and sIgA in patients with ulcerative Colonic bacterial proteases to IgA 1 (2006) (0)
- Adhesion Molecules in the Gastrointestinal Tract-A Search for Novel Cell Surface Molecules Upregulated in Inflammatory Bowel Disease (1994) (0)
- Effects of olsalazine in the j ej unum of the rat (2006) (0)
- Reply (1991) (0)
- Subclinical intestinal mucosal inflammation in diarrhoea predominant irritable bowel syndrome in a tropical setting (2010) (0)
- Liver and biliary Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis (2006) (0)
- A two-stage association study between inflammatory bowel disease and polymorphisms spanning GNAI2 (2001) (0)
- The PLA2G2A gene shows no major influence in the genetic susceptibility of IBD (2007) (0)
- Crypt Cell Proliferation (CCP) Hla-Dr Expression and Intra Epithelial Lymphocytes (IEL) in Pelvic Ileal Pouches (1990) (0)
- NITRIC OXIDE IN ULCERATIVE COLITIS. AUTHORS' REPLY (1995) (0)
- T1824 Sub Clinical Intestinal Mucosal Inflammation in Diarrhea Predominant Irritable Bowel Syndrome (IBS) in a Tropical Setting (2010) (0)
- M1129 Does the Clinical Phenotype of Inflammatory Bowel Disease Differ Between Caucasian and South Asian Patients Living in the UK (2009) (0)
- 96 The Wnt Co-Receptor LRP6 as a New Factor in Ileal Crohn's Disease (2012) (0)
- Thank you to reviewers (2021) (0)
- Polymorphisms in the MEP1A Gene: A Role in Inflammatory Bowel Disease (IBD)? (2004) (0)
- A replication study of the inflammatory bowel disease region on 6p. (2000) (0)
- DP ALLELES DO NOT INDEPENDENTLY CONFER SUSCEPTIBILITY TO CELIAC-DISEASE (1989) (0)
- Mucus Production and Its Sulphation in the Normal Colonic Mucosa and in Patients with Left-Sided Ulcerative Colitis (UC) (1990) (0)
- FUTURE DIRECTIONS FOR IMMUNOLOGICAL RESEARCH (1986) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Derek Parry Gastroenter Jewell?
Derek Parry Gastroenter Jewell is affiliated with the following schools: